Stress Hormone–Mediated Invasion of Ovarian Cancer Cells
Top Cited Papers
- 15 January 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (2) , 369-375
- https://doi.org/10.1158/1078-0432.ccr-05-1698
Abstract
Purpose: There is growing evidence that stress and other behavioral factors may affect cancer progression and patient survival. The underlying mechanisms for this association are poorly understood. The purpose of this study is to determine the effects of stress-associated hormones norepinephrine, epinephrine, and cortisol on the invasive potential of ovarian cancer cells. Experimental Design: The ovarian cancer cells EG, SKOV3, and 222 were exposed to increasing levels of either norepinephrine, epinephrine, or cortisol, and the in vitro invasive potential was determined using the membrane invasion culture system. Additionally, the effects of these stress hormones on matrix metalloproteinase-2 (MMP-2) and MMP-9 were determined by ELISA. The effects of the β-adrenergic agonist isoproterenol on in vivo tumor growth were determined using nude mice. Results: Stress levels of norepinephrine increased the in vitro invasiveness of ovarian cancer cells by 89% to 198%. Epinephrine also induced significant increases in invasion in all three cell lines ranging from 64% to 76%. Cortisol did not significantly affect invasiveness of the EG and 222 cell lines but increased invasion in the SKOV3 cell line (P = 0.01). We have previously shown that ovarian cancer cells express β-adrenergic receptors. The β-adrenergic antagonist propanolol (1 μmol/L) completely blocked the norepinephrine-induced increase in invasiveness. Norepinephrine also increased tumor cell expression of MMP-2 (P = 0.02 for both SKOV3 and EG cells) and MMP-9 (P = 0.01 and 0.04, respectively), and pharmacologic blockade of MMPs abrogated the effects of norepinephrine on tumor cell invasive potential. Isoproterenol treatment resulted in a significant increase in tumor volume and infiltration in the SKOV3ip1 in vivo model, which was blocked by propranolol. Conclusions: These findings provide direct experimental evidence that stress hormones can enhance the invasive potential of ovarian cancer cells. These effects are most likely mediated by stimulation of MMPs.Keywords
This publication has 69 references indexed in Scilit:
- Stress-induced immune dysfunction: implications for healthNature Reviews Immunology, 2005
- The cAMP-Epac-Rap1 Pathway Regulates Cell Spreading and Cell Adhesion to Laminin-5 through the α3β1 Integrin but Not the α6β4 IntegrinJournal of Biological Chemistry, 2004
- Psychological, Behavioral, and Immune Changes After a Psychological Intervention: A Clinical TrialJournal of Clinical Oncology, 2004
- Functional role of matrix metalloproteinases in ovarian tumor cell plasticityAmerican Journal of Obstetrics and Gynecology, 2004
- Norepinephrine, the β-Adrenergic Receptor, and ImmunityBrain, Behavior, and Immunity, 2002
- Functional Interplay between Type I Collagen and Cell Surface Matrix Metalloproteinase ActivityJournal of Biological Chemistry, 2001
- How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative ActionsEndocrine Reviews, 2000
- Immobilization stress elevates gene expression for catecholamine biosynthetic enzymes and some neuropeptides in rat sympathetic ganglia: effects of adrenocorticotropin and glucocorticoidsEndocrinology, 1996
- Quality of Life in Phase II Trials: a Study of Methodology and Predictive Value in Patients With Advanced Breast Cancer Treated With Paclitaxel Plus Granulocyte Colony-Stimulating FactorJNCI Journal of the National Cancer Institute, 1995
- Immunological and Psychosocial Predictors of Disease Recurrence in Patients with Early-Stage Breast CancerBehavioral Medicine, 1991